![(2S,3S)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl beta-D-glucopyranoside in PDB entry 2m9s, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/2m9s_entity_2_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>2m9s</span> contains 2 copies of <span class='highlight'>(2S,3S)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl beta-D-glucopyranoside</span>. Side view.")
![(2S,3S)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl beta-D-glucopyranoside in PDB entry 2m9s, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/2m9s_entity_2_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>2m9s</span> contains 2 copies of <span class='highlight'>(2S,3S)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl beta-D-glucopyranoside</span>. Top view.")
Environment details NEW
23Y 101 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.